With tariffs set to take effect Oct. 1 on certain pharmaceuticals, major drugmakers have been accelerating investments in U.S. manufacturing.  Here are five updates: 

Companies share a commitment to helping patients get the medications they need quickly, affordably, and with price transparency BOSTON, July 22, 2025 (GLOBE NEWSWIRE) — DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions to more than 250,000…

The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer that has progressed following at least one prior endocrine therapy.  The approval…

Fairview Pharmacy Services is relocating to a larger facility in Shoreview, Minn., to expand operations to meet rising demand for pharmacy services.  The move comes amid a national increase in prescription drug use and a growing number of pharmacy closures,…

A growing number of states are taking action to ensure broad access to COVID-19 vaccines as respiratory virus season approaches. The state-level moves come after the FDA limited approval of updated shots to individuals 65 and older, and those with…

Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 per month beginning next year, expanding an existing program. “Our announcement builds on an idea…

Nashville, TN and San Francisco, CA — September 22, 2025 — Vanderbilt University Medical Center (VUMC) has selected Latent, an AI-enabled medication access platform, to support specialty and infusion prior authorization workflows. The effort is designed to streamline administrative processes…

HHS is taking new steps to speed the development and review of new cell and gene therapies in the U.S. Three things to know: 1. The FDA published three draft guidances Sept. 24 detailing strategies for drugmakers to streamline the…

The American Society of Health-System Pharmacists has launched the  ASHP Center for Next Generation Therapeutics, aimed at supporting hospitals and health systems to navigate cell and gene therapy treatments along with other high-cost therapies.  The center is set to prioritize…

Pharmacy benefit managers are working on a proposal to change certain business practices in an effort to curb potential regulation from the Trump administration, Bloomberg reported Sept. 24.  Here are four things to know: